Alexandra Iulia Aghiorghiesei, Andreea Nutu, Nikolay Mehterov, Christos K. Kontos, Boyan Vladimirov, Rares Buduru, Cornelia Braicu, Ioana Berindan-Neagoe
{"title":"miR-181家族成员在OSCC中的作用:对治疗和诊断的意义","authors":"Alexandra Iulia Aghiorghiesei, Andreea Nutu, Nikolay Mehterov, Christos K. Kontos, Boyan Vladimirov, Rares Buduru, Cornelia Braicu, Ioana Berindan-Neagoe","doi":"10.1002/cam4.71266","DOIUrl":null,"url":null,"abstract":"<p>Oral squamous cell carcinoma (OSCC) is a common and aggressive form of head and neck cancer, frequently associated with smoking, alcohol consumption, and HPV infection. MicroRNAs (miRNAs) are small, non-coding RNA transcripts that play significant roles in cancer initiation and progression. In this study, we focused on the miR-181 family members' influence on OSCC tumorigenesis and progression, focusing on their distinct biological functions and regulatory mechanisms in OSCC-specific contexts. Attention was given to the potential of these transcripts as biomarkers, considering their differential expression in OSCC tissues and biofluids such as plasma, serum, and saliva. Alterations in salivary miR-181 levels have been correlated with different stages of oral lesion progression, underscoring their utility as non-invasive biomarkers for early detection and risk stratification. Moreover, we discuss the implications of miR-181 family modulation on biological processes in preclinical OSCC studies, highlighting their involvement in cancer hallmarks, including invasion, migration, metastasis, radio- and chemotherapy resistance. These findings underscore the therapeutic and diagnostic potential of the miR-181 family in OSCC management.</p>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"14 19","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71266","citationCount":"0","resultStr":"{\"title\":\"Roles of miR-181 Family Members in OSCC: Implications for Therapy and Diagnostics\",\"authors\":\"Alexandra Iulia Aghiorghiesei, Andreea Nutu, Nikolay Mehterov, Christos K. Kontos, Boyan Vladimirov, Rares Buduru, Cornelia Braicu, Ioana Berindan-Neagoe\",\"doi\":\"10.1002/cam4.71266\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Oral squamous cell carcinoma (OSCC) is a common and aggressive form of head and neck cancer, frequently associated with smoking, alcohol consumption, and HPV infection. MicroRNAs (miRNAs) are small, non-coding RNA transcripts that play significant roles in cancer initiation and progression. In this study, we focused on the miR-181 family members' influence on OSCC tumorigenesis and progression, focusing on their distinct biological functions and regulatory mechanisms in OSCC-specific contexts. Attention was given to the potential of these transcripts as biomarkers, considering their differential expression in OSCC tissues and biofluids such as plasma, serum, and saliva. Alterations in salivary miR-181 levels have been correlated with different stages of oral lesion progression, underscoring their utility as non-invasive biomarkers for early detection and risk stratification. Moreover, we discuss the implications of miR-181 family modulation on biological processes in preclinical OSCC studies, highlighting their involvement in cancer hallmarks, including invasion, migration, metastasis, radio- and chemotherapy resistance. These findings underscore the therapeutic and diagnostic potential of the miR-181 family in OSCC management.</p>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"14 19\",\"pages\":\"\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.71266\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71266\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.71266","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Roles of miR-181 Family Members in OSCC: Implications for Therapy and Diagnostics
Oral squamous cell carcinoma (OSCC) is a common and aggressive form of head and neck cancer, frequently associated with smoking, alcohol consumption, and HPV infection. MicroRNAs (miRNAs) are small, non-coding RNA transcripts that play significant roles in cancer initiation and progression. In this study, we focused on the miR-181 family members' influence on OSCC tumorigenesis and progression, focusing on their distinct biological functions and regulatory mechanisms in OSCC-specific contexts. Attention was given to the potential of these transcripts as biomarkers, considering their differential expression in OSCC tissues and biofluids such as plasma, serum, and saliva. Alterations in salivary miR-181 levels have been correlated with different stages of oral lesion progression, underscoring their utility as non-invasive biomarkers for early detection and risk stratification. Moreover, we discuss the implications of miR-181 family modulation on biological processes in preclinical OSCC studies, highlighting their involvement in cancer hallmarks, including invasion, migration, metastasis, radio- and chemotherapy resistance. These findings underscore the therapeutic and diagnostic potential of the miR-181 family in OSCC management.
期刊介绍:
Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas:
Clinical Cancer Research
Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations
Cancer Biology:
Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery.
Cancer Prevention:
Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach.
Bioinformatics:
Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers.
Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.